Further evidence of the benefits of treating Alzheimer‚s disease patients with Lundbeck’s glutamate antagonist, Ebixa (memantine), has come from a 1,845-patient study presented at the 7th ...

For the first time in New Zealand a new drug is bringing help to patients in the later stages of Alzheimer's disease and vital relief to those who care for them. EBIXA (memantine) is the first in a ...

People with advanced Alzheimer's disease could be prescribed a new drug by next week. Health Canada has approved the drug Ebixa or Memantine, the first one to show positive results in people with ...

The UAE Ministry of Health has ordered withdrawal of product Ebixa (memantine hydrochloride) 5mg, which is manufactured by Lundbeck. According to a report in ‘Gulf Today’, the order follows withdrawal ...